Doripenem
Doripenem is a broad-spectrum carbapenem antibiotic used to treat certain serious bacterial infections, particularly complicated intra-abdominal infections and complicated urinary tract infections, including pyelonephritis, where approved. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial cell death. Doripenem is administered by intravenous infusion in a hospital setting, with dosage adjusted according to kidney function and the severity of infection. Common adverse effects include nausea, diarrhoea, headache, and infusion-site reactions. Important precautions include potential allergic reactions in patients with beta-lactam antibiotic allergies, an increased risk of seizures in susceptible patients, and interactions with certain medicines such as valproate. Doripenem is not appropriate for every infection, and its use should be guided by local approvals, bacterial susceptibility, and antimicrobial stewardship recommendations.
Doripenem was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Doripenem, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Doripenem from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Doripenem, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
